Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective study
Neurogene Diarrhö nach SMA-Entkleidung oder -Resektion bei Pankreasadenokarzinom nach präoperativer Chemotherapie: internationale multizentrische retrospektive Studie
BJS Open · 12.05.2026 · 10 (3)
DOI: 10.1093/bjsopen/zrag057 ↗Auf einen Blick
Bei 291 operierten Patient:innen trat postoperative neurogene Diarrhö häufig auf. Das Risiko war nach > 180° SMA-Entkleidung oder SMA-Resektion höher; ein Einfluss auf das Gesamtüberleben zeigte sich nicht.
Fragestellung
Wie häufig tritt neurogene Diarrhö nach SMA-Entkleidung/-Resektion bei Pankreasadenokarzinom auf, welche Faktoren sind damit assoziiert und beeinflusst sie das Überleben?
Methode
Multizentrische retrospektive Studie mit konsekutiven Patient:innen nach präoperativer Chemotherapie mit oder ohne Radiotherapie zwischen 2016 und 2022.
Ergebnisse
291 Patient:innen; 193 entwickelten postoperative neurogene Diarrhö. Angepasstes Risiko: 59 % (95 %-KI 46–73) nach ≤ 180° SMA-Entkleidung, 80 % (95 %-KI 67–93) nach > 180° und 77 % (95 %-KI 66–88) nach SMA-Resektion. HR für OS 0,83 (95 %-KI 0,55–1,25).
Schlussfolgerung der Autor:innen
Neurogene Diarrhö trat bei zwei Dritteln nach Resektion mit begleitender SMA-Entkleidung/-Resektion auf, besonders nach > 180° Entkleidung oder Resektion. Sie war nicht mit einem beeinträchtigten Gesamtüberleben assoziiert.
Kernaussagen
- 193 von 291 Patient:innen entwickelten postoperative neurogene Diarrhö
- Höheres Risiko nach > 180° SMA-Entkleidung oder SMA-Resektion
- Kein signifikanter Zusammenhang mit dem Gesamtüberleben
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Multizentrische Studie in der Zeitschrift BJS Open, online erschienen am 09.06.2026. Verfasst von Thomas F Stoop und 40 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Adenocarcinoma, Mesenteric Artery, Superior, Diarrhea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dutch Cancer Society, Deltaplan Alvleesklierkanker, Cultuurfonds.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The increased use of superior mesenteric artery (SMA) divestment has been a driver behind the increased resection rate for locally advanced pancreatic cancer following preoperative therapy. This has also resulted in an increase in the rate of postoperative neurogenic diarrhoea, but knowledge about postoperative neurogenic diarrhoea is lacking. The aims of this study were to determine the incidence, risk factors, management, and outcomes of neurogenic diarrhoea after SMA divestment/resection for pancreatic adenocarcinoma.
Methods
This multicentre retrospective study included consecutive patients undergoing pancreatic adenocarcinoma resection, including SMA divestment/resection, after preoperative chemotherapy with or without radiotherapy between 2016 and 2022. Primary endpoints were the incidence of postoperative neurogenic diarrhoea, associated factors, treatment strategies, and outcomes. Secondary endpoints were the rate of adjuvant chemotherapy and the impact of neurogenic diarrhoea on overall survival (OS).
Results
Overall, 291 patients who underwent pancreatic resection with concomitant SMA divestment (240, 82%) or resection (51, 18%) were included in the study. Postoperative neurogenic diarrhoea was diagnosed in 193 patients. The adjusted risk of developing neurogenic diarrhoea was 59% (95% confidence interval (c.i.) 46 to 73) after ≤ 180° SMA divestment, 80% (95% c.i. 67 to 93) after > 180° SMA divestment, and 77% (95% c.i. 66 to 88) after SMA resection. Postoperative neurogenic diarrhoea was treated with non-opioid drugs (29, 15%), non-opium opioids (140, 73%), opium tincture (69, 36%), and/or octreotide (49, 25%), and normalized in 51% of patients. After adjusting for confounders, neurogenic diarrhoea was not significantly associated with OS (hazard ratio 0.83; 95% c.i. 0.55 to 1.25).
Conclusion
Neurogenic diarrhoea occurred in two-thirds of patients following resection of pancreatic adenocarcinoma with concomitant SMA divestment/resection, particularly after > 180° SMA divestment or SMA resection. Although challenging to manage, neurogenic diarrhoea is not associated with impaired OS. Evidence-based treatment strategies are needed for adequate management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
- Cancer Center Amsterdam, Amsterdam, the Netherlands.
- Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Department of Hepatobiliary and Pancreatic Surgery, Institute of Science Tokyo, Tokyo, Japan.
- Amsterdam UMC, Location Vrije University, Department of Surgery, Amsterdam, the Netherlands.
ORCID-Profile: Mahsoem Ali, Atsushi Oba, Bas Groot Koerkamp, Carl-Stephan Leonhardt, Manuela Mastronardi, Olivier R Busch, Oskar Franklin, Ulla Klaiber, Toshitaka Sugawara, Marc G Besselink
Förderung
- Dutch Cancer Society
- Deltaplan Alvleesklierkanker
- Cultuurfonds
- Cancer Center Amsterdam
- Royal Swedish Academy of Sciences
- Swedish Society of Medicine
- Region Västerbotten in Umeå, Sweden
- Sjöberg Foundation
Zitieren
APA
Stoop, T. F., Croce, C., Ishida, H., Ali, M., Javed, A. A., Halimi, A., Oba, A., Groot Koerkamp, B., Leonhardt, C. S., Thiels, C. A., Rangelova, E., Sparrelid, E., Sotirova, I., Leiting, J. L., Tauchi, J., Kobayashi, K., Klos, M., Beuk, L. P. M., Genova, L., …, & International Collaboration on Advanced Pancreatic Cancer (2026). Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective study. BJS Open, 10(3). https://doi.org/10.1093/bjsopen/zrag057
Vancouver
Stoop TF, Croce C, Ishida H, Ali M, Javed AA, Halimi A, et al. Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective study. BJS Open. 2026;10(3). doi:10.1093/bjsopen/zrag057
BibTeX
@article{Stoop2026,
author = {Stoop, Thomas F and Croce, Chiara and Ishida, Hiroyuki and Ali, Mahsoem and Javed, Ammar A and Halimi, Asif and Oba, Atsushi and Groot Koerkamp, Bas and Leonhardt, Carl-Stephan and Thiels, Cornelius A and Rangelova, Elena and Sparrelid, Ernesto and Sotirova, Ira and Leiting, Jennifer L and Tauchi, Jun and Kobayashi, Kosuke and Klos, Marit and Beuk, Lysanne P M and Genova, Luana and Mastronardi, Manuela and Kendrick, Michael L and Mughal, Nabiha A and Busch, Olivier R and Franklin, Oskar and Larsson, Patrik and Klaiber, Ulla and Schulick, Richard D and Theijse, Rutger T and Strobel, Oliver and Ghorbani, Poya and de Wilde, Roeland F and Rodriguez Franco, Salvador and Sugawara, Toshitaka and Wilmink, Johanna W and Messersmith, Wells and Besselink, Marc G and Wolfgang, Christopher L and Inoue, Yosuke and Truty, Mark J and Del Chiaro, Marco and International Collaboration on Advanced Pancreatic Cancer, International Collaboration on Advanced Pancreatic Cancer},
title = {Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective study},
journal = {BJS Open},
year = {2026},
volume = {10},
number = {3},
doi = {10.1093/bjsopen/zrag057}
}
EUVIMED